Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
  1. 4 Open-market buy Director bought 10,000 shares at $3.10 ($31,000)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4/A Open-market buy 10% owner bought 10,136 shares at an average $4.78 ($48,487)
  11. 4 Open-market buy 10% owner bought 10,136 shares at an average $4.78 ($48,487)
  12. 4 Open-market buy Director bought 10,000 shares at $4.25 ($42,500)
  13. 4 Open-market buy Director bought 10,000 shares at $4.46 ($44,555)
  14. 4/A Insider Changes in Ownership
  15. 5 Insider Annual Insider Trading Report
  16. 4 Open-market buy 10% owner bought 24,031 shares at $4.96 ($119,271)
  17. 4 Shares withheld for taxes Chf Scientific Operations Off gave up 4,603 shares (to pay taxes)
  18. 4 Shares withheld for taxes CEO and President gave up 5,080 shares (to pay taxes)
  19. 4 Grant or award Chief Medical Officer acquired 13,500 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 7 of 20 · 382 filings